-
2024 Innovative Practices Winners in Informatics, Collaboration, Clinical IT, Genomics
Mar 19 | Bio-IT World | Bio-IT World today announced the 2024 Innovative Practices Awards winners. Six projects were honored. Companies driving the winning entries included AstraZeneca, DNAnexus, Pistoia Alliance, Regeneron, Tempus, and UK Biobank. More -
Five Global Teams Tackling Cancer Grand Challenges
Mar 14 | Bio-IT World | Cancer Grand Challenges—a global funding initiative co-founded by the National Cancer Institute and Cancer Research UK—has announced five new global teams selected to each receive up to $25M over five years to take on four of cancer’s toughest challenges. More -
Citizen-Driven Research Aids Development Of Digital Biomarkers For ALS
Mar 13 | Bio-IT World | When it comes to research on amyotrophic lateral sclerosis (ALS), every stakeholder—most especially patients—knows time is of the essence. From diagnosis to death, life expectancy from the debilitating neuromuscular disease can be two years or less. More -
Biology-Based Diagnostic Criteria For Parkinson’s Disease Research
Mar 12 | Bio-IT World | Scientists from a trio of countries are calling for a new, more comprehensive way of classifying Parkinson’s disease for diagnostic research purposes that considers an individual’s biology. The disorder might thereby be detected before patients have any symptoms, as is now the case for cancer and diabetes. More -
Human Biomolecular Atlas Program Update
Mar 07 | Bio-IT World | The NIH Common Fund Human Biomolecular Atlas Program (HuBMAP) is trying to map—to create a reference atlas—of the 37 trillion human cells in our body. Work is underway on a male and female reference atlas that could help us better understand what is normal when we are healthy and help shed light on how we change as we age or as other bodily changes, such as pregnancy, occur. More -
Adama Ibrahim on Embracing Change and Overcoming Resistance
Mar 06 | Bio-IT World | Change naturally happens everywhere. Yet, it is often met with resistance—sometimes even with outright hostility. But in an ever-evolving world, change is needed to inspire innovation and create new opportunities, and the biotech industry is no different. The question is, how do we overcome resistance? More -
Bio-IT World Launches Exclusive Venture, Investing Event
Mar 05 | Bio-IT World | The Bio-IT World Conference & Expo has launched a new co-located event this year—the Bio-IT World Venture, Innovation, and Partnering Conference, held on Wednesday, April 17, overlapping with the last day of the Bio-IT World Conference. More -
Oxford Nanopore and Lonza Team Up, Medidata and Sanofi Vaccines Collaborate, More
Feb 29 | Bio-IT World | Oxford Nanopore and Lonza have teamed up to cGMP validate and commercialize a first-of-its-kind novel test to accurately determine multiple critical quality attributes of mRNA products by directly sequencing both the DNA template and the messenger RNA; Parse updates whole transcriptome kit; and more. More -
Ginkgo Bioworks Announces Three Acquisitions
Feb 28 | Bio-IT World | Ginkgo Bioworks announced three acquisitions today: Reverie Labs, Proof Diagnostics, and Patch Biosciences. The acquisitions will expand Ginkgo’s capabilities for large-scale AI foundation models, its library of RNA programmable, non-Cas enzymes, and its machine learning models and downstream assays. More -
Follow the Money: Cancer Early Detection Tests, Self-Sampling Solutions Expansion, Multiple Product Advancement
Feb 28 | Bio-IT World | Freenome will advance the pipeline of single-cancer and tailored multi-cancer early detection tests built on its multiomics platform; Capitainer plans to advance its journey toward becoming the foremost provider of self-sampling solutions with new funding, including scaling up production capacity, enhancing sales and marketing strategies, and launching new products; COUR will advance multiple, wholly owned product candidates that leverage the company’s immune tolerance platform, including Phase 2a proof-of-concept clinical studies in Myasthenia Gravis and Type 1 Diabetes, and other pipeline opportunities; and more. More
Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and
data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!
Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!